Godrej Agrovet (GAVL) has received an approval from its board to amalgamate Astec LifeSciences with itself in consideration for equity shares of GAVL. The company will issue and allot 11 fully paid up equity shares of Rs 10 each to the equity shareholders of Astec as on Record Date, for every 10 fully paid up equity shares of Rs 10 each held by them in Astec.
The Board of Directors of the company at their meeting held on September 14, 2018, approved the same.
Godrej Agrovet is a diversified, research and development focused agri-business company with operations across five business verticals i.e. animal feed, crop protection, oil palm, dairy, and poultry and processed foods.
